ImaginAb Executes New License and Supply Agreement for CD8 ImmunoPET Technology with Leucid Bio

/PRNewswire/ -- ImaginAb Inc., a global biotechnology company developing 89Zr crefmirlimab berdoxam (CD8 ImmunoPET™) imaging agent and radiopharmaceutical...

Related Keywords

London ,City Of ,United Kingdom ,Leucid Bio ,Ian Wilson ,John Maher ,King College London ,Prnewswire Imaginab Inc ,Imaginab Inc ,Supply Agreement ,Chimeric Antigen Receptort Cell ,Chief Executive Officer ,Chief Business Officer ,College London ,Imaginab ,Nc ,